Skip to main content

858 publications

Name Date Type Actions

ANNUAL RESULTS 2023 (slideshow)

01.2023 Highlights
02.2023 Consolidated financial statements
03.Strategy and outlook

20/03/2024 Annual Report

2023 ANNUAL RESULTS

Annual sales: €529m (stable at constant exchange rates)
Essentials sales: €313m (+4.5% at constant exchange rates)
Net income - Group share: €56m (10.5% of sales)
EBITDA: €113m (21.3% of sales)
Free cash-flow: €89m

20/03/2024 Public releases

Monthly information regarding the total number of voting rights – February 2024

As per articles L2338II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »As per articles L2338II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

05/03/2024 Voting rights

Monthly information regarding the total number of voting rights – January 2024

As per articles L2338II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

 

02/02/2024 Voting rights

Buyback programs – January 2024

Monthly communication regarding buyback programs

02/02/2024 Description of buyback programs

Annual sales 2023: €529 million

Annual Sales of Essential products: €313 million (up 4.5% at constant exchange rates)

24/01/2024 Public releases

Monthly information regarding the total number of voting rights – December 2023

As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

04/01/2024 Voting rights

2024 Calendar of financial communication

Vetoquinol published its calendar of financial communication for 2024.

03/01/2024 Agenda

Buyback programs - November 2023

Monthly communication regarding buyback programs

04/12/2023 Description of buyback programs

Buyback programs - december 2023

Monthly communication regarding buyback programs

03/12/2023 Description of buyback programs